FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1884328665> ?p ?o ?g. }

• W1884328665 endingPage "182" @default.
• W1884328665 startingPage "177" @default.
• W1884328665 abstract "Objective To determine whether it is practicable to use intraperitoneal calcitriol to treat continuous ambulatory peritoneal dialysis (CAPD) patients with secondary hyperparathyroidism and whether this form of therapy is effective and safe. Design A prospective, nonrandomized study. Setting Division of Nephrology, Tertiary Hospital. Method Eight patients from our CAPD population were recruited (5 F,3 M), aged 24 to 63 years (mean 38.9 ± 7.6 yr). They had been on CAPD for 8 to 84 months (mean 47.6 ± 24.6 months). All the patients had bone biopsy -proven secondary hyperparathyroidism with 2 patients showing mixed lesions. The CAPD system was changed to the twinbag system (Ultrabag, Baxter Healthcare, McGaw Park, IL, U.S.A.) in all 8 patients, who were taught to inject the calcitriol directly through the short transfer set and the Tenckhoff catheter into the peritoneal cavity, twice per week before bedtime. Calcium carbonate or calcium acetate was used as the main phosphate binder. Intact parathyroid hormone level (iPTH), serum ionized calcium (iCa), serum phosphate, and serum total alkaline phosphatase (alk. phos.) levels were measured at baseline and then every 4 weeks. The mean duration of follow-up was 10.5 months ± 1.9 months. Results There was a significant drop of iPTH level from the pretreatment level of 100.6 ± 35.8 pmoll L to a level of 63.8 ± 48.7 pmoll L at 24 weeks (p = 0.036). The lowest level of iPTH attained was 43.4 ± 27.0 pmol/L at 48 weeks. Serum total alk. phos. also dropped from 232.4 ± 83.3 lUlL pretreatment to 147.9 ± 52.0 lUlL at 24 weeks (p = 0.017). The decrease in alk. phos. level paralleled the decrease in iPTH level. The mean serum iCa level did not show any significant rise throughout the study period. The maximum dose of calcitriol used was 6.6 ± 1.5 μg/week and the average dose of calcitriol was 5.4 ± 1.2 μg/week. One patient did not respond satisfactorily and she subsequently had a parathyroidectomy. Two episodes of peritonitis occurred during the study period, giving a peritonitis rate of one episode per 42 patient-months. There was no significant change in the urea clearance tests or the peritoneal equilibration tests before and after the study. Conclusion Intraperitoneal calcitriol is practicable, effective, and safe in the treatment of secondary hyperparathyroidism in CAPD patients." @default.
• W1884328665 created "2016-06-24" @default.
• W1884328665 creator A5005204728 @default.
• W1884328665 creator A5033718553 @default.
• W1884328665 creator A5034362951 @default.
• W1884328665 creator A5039429698 @default.
• W1884328665 creator A5058280153 @default.
• W1884328665 creator A5069846970 @default.
• W1884328665 creator A5072293213 @default.
• W1884328665 creator A5072300300 @default.
• W1884328665 creator A5079038331 @default.
• W1884328665 date "1998-03-01" @default.
• W1884328665 modified "2023-10-15" @default.
• W1884328665 title "Intraperitoneal Pulse Calcitriol in the Treatment of Secondary Hyperparathyroidism in Patients on Continuous Ambulatory Peritoneal Dialysis" @default.
• W1884328665 cites W1963633537 @default.
• W1884328665 cites W1972297013 @default.
• W1884328665 cites W1999778136 @default.
• W1884328665 cites W2031888876 @default.
• W1884328665 cites W2038133666 @default.
• W1884328665 cites W2039127386 @default.
• W1884328665 cites W2055923382 @default.
• W1884328665 cites W2070530147 @default.
• W1884328665 cites W2082228528 @default.
• W1884328665 cites W2103234678 @default.
• W1884328665 cites W2113219485 @default.
• W1884328665 cites W2113756317 @default.
• W1884328665 cites W2130054095 @default.
• W1884328665 cites W2152928463 @default.
• W1884328665 doi "https://doi.org/10.1177/089686089801800206" @default.
• W1884328665 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9576366" @default.
• W1884328665 hasPublicationYear "1998" @default.
• W1884328665 type Work @default.
• W1884328665 sameAs 1884328665 @default.
• W1884328665 citedByCount "4" @default.
• W1884328665 countsByYear W18843286652014 @default.
• W1884328665 countsByYear W18843286652016 @default.
• W1884328665 crossrefType "journal-article" @default.
• W1884328665 hasAuthorship W1884328665A5005204728 @default.
• W1884328665 hasAuthorship W1884328665A5033718553 @default.
• W1884328665 hasAuthorship W1884328665A5034362951 @default.
• W1884328665 hasAuthorship W1884328665A5039429698 @default.
• W1884328665 hasAuthorship W1884328665A5058280153 @default.
• W1884328665 hasAuthorship W1884328665A5069846970 @default.
• W1884328665 hasAuthorship W1884328665A5072293213 @default.
• W1884328665 hasAuthorship W1884328665A5072300300 @default.
• W1884328665 hasAuthorship W1884328665A5079038331 @default.
• W1884328665 hasConcept C124490489 @default.
• W1884328665 hasConcept C126322002 @default.
• W1884328665 hasConcept C126894567 @default.
• W1884328665 hasConcept C134018914 @default.
• W1884328665 hasConcept C141071460 @default.
• W1884328665 hasConcept C2775945674 @default.
• W1884328665 hasConcept C2776036575 @default.
• W1884328665 hasConcept C2776079296 @default.
• W1884328665 hasConcept C2778653478 @default.
• W1884328665 hasConcept C2778838027 @default.
• W1884328665 hasConcept C2779056158 @default.
• W1884328665 hasConcept C2781208988 @default.
• W1884328665 hasConcept C2908647359 @default.
• W1884328665 hasConcept C2909406889 @default.
• W1884328665 hasConcept C35785553 @default.
• W1884328665 hasConcept C519063684 @default.
• W1884328665 hasConcept C71924100 @default.
• W1884328665 hasConcept C90924648 @default.
• W1884328665 hasConcept C99454951 @default.
• W1884328665 hasConceptScore W1884328665C124490489 @default.
• W1884328665 hasConceptScore W1884328665C126322002 @default.
• W1884328665 hasConceptScore W1884328665C126894567 @default.
• W1884328665 hasConceptScore W1884328665C134018914 @default.
• W1884328665 hasConceptScore W1884328665C141071460 @default.
• W1884328665 hasConceptScore W1884328665C2775945674 @default.
• W1884328665 hasConceptScore W1884328665C2776036575 @default.
• W1884328665 hasConceptScore W1884328665C2776079296 @default.
• W1884328665 hasConceptScore W1884328665C2778653478 @default.
• W1884328665 hasConceptScore W1884328665C2778838027 @default.
• W1884328665 hasConceptScore W1884328665C2779056158 @default.
• W1884328665 hasConceptScore W1884328665C2781208988 @default.
• W1884328665 hasConceptScore W1884328665C2908647359 @default.
• W1884328665 hasConceptScore W1884328665C2909406889 @default.
• W1884328665 hasConceptScore W1884328665C35785553 @default.
• W1884328665 hasConceptScore W1884328665C519063684 @default.
• W1884328665 hasConceptScore W1884328665C71924100 @default.
• W1884328665 hasConceptScore W1884328665C90924648 @default.
• W1884328665 hasConceptScore W1884328665C99454951 @default.
• W1884328665 hasIssue "2" @default.
• W1884328665 hasLocation W18843286651 @default.
• W1884328665 hasLocation W18843286652 @default.
• W1884328665 hasOpenAccess W1884328665 @default.
• W1884328665 hasPrimaryLocation W18843286651 @default.
• W1884328665 hasRelatedWork W1972837054 @default.
• W1884328665 hasRelatedWork W1976997529 @default.
• W1884328665 hasRelatedWork W2078115324 @default.
• W1884328665 hasRelatedWork W2273105062 @default.
• W1884328665 hasRelatedWork W2340530270 @default.
• W1884328665 hasRelatedWork W2363272031 @default.
• W1884328665 hasRelatedWork W2392778255 @default.
• W1884328665 hasRelatedWork W2410697176 @default.
• W1884328665 hasRelatedWork W2418473254 @default.

• next